Samsung Biologics seeks over $2B funding for PolyPeptide deal
Samsung Biologics seeks to raise over $2B to fund a PolyPeptide deal and expansion.
Story updates
02:21:42 AM UTC
SquawkNews
Samsung Biologics Seeks to Raise Over $2 Billion to Fund PolyPeptide Deal, Expansion — Update
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.